Literature DB >> 26886249

Association of Breast Conservation Surgery for Cancer With 90-Day Reoperation Rates in New York State.

Abby J Isaacs1, Mary L Gemignani2, Andrea Pusic2, Art Sedrakyan1.   

Abstract

IMPORTANCE: For early-stage breast cancer, breast conservation surgery (BCS) is a conservative option for women and involves removing the tumor with a margin of surrounding breast tissue. If margins are not tumor free, patients undergo additional surgery to avoid local recurrence.
OBJECTIVES: To investigate the use of BCS in New York State and to determine rates of reoperation, procedure choice, and the effect of surgeon experience on the odds of a reoperation 90 days after BCS. DESIGN, SETTING, AND PARTICIPANTS: A population-based sample of 89 448 women undergoing primary BCS for cancer were selected and examined from January 1, 2003, to December 31, 2013, in New York State mandatory reporting databases. All hospitals and ambulatory surgery centers in New York State were included. Data were analyzed from December 15, 2014, to November 1, 2015. MAIN OUTCOMES AND MEASURES: Rate of reoperations within 90 days of the initial BCS procedure.
RESULTS: During the study period, 89 448 women 20 years or older (mean [SD] age, 61.7 [13.7] years) underwent primary BCS. In 2013, 1416 women in New York aged 20 to 49 years underwent BCS compared with 3068 women aged 50 to 64 years and 3644 women 65 years or older. These numbers represent a significant decrease from 1960 women younger than 50 years in 2003 who underwent BCS (P < .001 for trend) but little change from the 2899 women aged 50 to 64 years and 3270 women 65 years or older who underwent BCS in 2003. Mean overall rate of 90-day reoperation was 30.9% (27 010 of 87 499 patients) and decreased over time from 39.5% (6630 of 16 805 patients) in 2003 to 2004 to 23.1% (5148 of 22 286 patients) in 2011 to 2013. Rates of reoperation were highest in women aged 20 to 49 years (37.7% [6990 of 18 524]) and lowest in women 65 years or older (26.3% [9656 of 36 691]) (P < .001 for trend). Over time, more patients underwent BCS as a subsequent procedure, from 4237 of 6630 patients (63.9%) in 2003 to 2004 to 4258 of 5148 (82.7%) in 2011 to 2013 (P < .001 for trend). Among the 19 466 women who underwent BCS as a second procedure, 2429 (12.5%) required a third intervention (2.7% of all women included). Significant surgeon-level variation was found in the data; 90-day rates of reoperations by surgeon ranged from 0% to 100%. Low-volume surgeons (<14 cases per year) had an unadjusted rate of 35.2% compared with 29.6% in middle-volume (14-33 cases per year) and 27.5% in high-volume (≥34 cases per year) surgeons. The difference persisted in adjusted analyses (odds ratio for low-volume surgeons, 1.49 [95% CI, 1.19-1.87]; for middle-volume surgeons, 1.20 [95% CI, 0.93-1.56]) compared with high-volume surgeons (used as the reference category). CONCLUSIONS AND RELEVANCE: Use of BCS has decreased overall, most steeply in younger women. Nearly 1 in 4 women underwent a reoperation within 90 days of BCS across New York State from 2011 to 2013, compared with 2 in 5 from 2003 to 2004. Rates vary significantly by surgeon, and initial BCS performed by high-volume surgeons was associated with a 33% lower risk for a reoperation.

Entities:  

Mesh:

Year:  2016        PMID: 26886249     DOI: 10.1001/jamasurg.2015.5535

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


  14 in total

1.  The Value of Repeated Breast Surgery as a Quality Indicator in Breast Cancer Care.

Authors:  Francesca Tamburelli; Riccardo Ponzone
Journal:  Ann Surg Oncol       Date:  2020-06-10       Impact factor: 5.344

2.  Prevalence and Consequences of Axillary Lymph Node Dissection in the Era of Sentinel Lymph Node Biopsy for Breast Cancer.

Authors:  Tina W F Yen; Purushottam W Laud; Liliana E Pezzin; Emily L McGinley; Erica Wozniak; Rodney Sparapani; Ann B Nattinger
Journal:  Med Care       Date:  2018-01       Impact factor: 2.983

Review 3.  Update of the American Society of Breast Surgeons Toolbox to address the lumpectomy reoperation epidemic.

Authors:  Maureen P McEvoy; Jeffrey Landercasper; Himani R Naik; Sheldon Feldman
Journal:  Gland Surg       Date:  2018-12

4.  Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center.

Authors:  Laura H Rosenberger; Anita Mamtani; Sarah Fuzesi; Michelle Stempel; Anne Eaton; Monica Morrow; Mary L Gemignani
Journal:  Ann Surg Oncol       Date:  2016-07-12       Impact factor: 5.344

5.  Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.

Authors:  Linnea Langhans; Maj-Britt Jensen; Maj-Lis M Talman; Ilse Vejborg; Niels Kroman; Tove F Tvedskov
Journal:  JAMA Surg       Date:  2017-04-01       Impact factor: 14.766

6.  Was Reexcision Less Frequent for Patients with Lobular Breast Cancer After Publication of the SSO-ASTRO Margin Guidelines?

Authors:  Anita Mamtani; Emily C Zabor; Laura H Rosenberger; Michelle Stempel; Mary L Gemignani; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2019-08-27       Impact factor: 5.344

7.  Margin Assessment and Re-excision Rates for Patients Who Have Neoadjuvant Chemotherapy and Breast-Conserving Surgery.

Authors:  Cindy Cen; Jennifer Chun; Elianna Kaplowitz; Deborah Axelrod; Richard Shapiro; Amber Guth; Freya Schnabel
Journal:  Ann Surg Oncol       Date:  2021-02-26       Impact factor: 5.344

8.  Rapid evaporative ionisation mass spectrometry of electrosurgical vapours for the identification of breast pathology: towards an intelligent knife for breast cancer surgery.

Authors:  Edward R St John; Julia Balog; James S McKenzie; Merja Rossi; April Covington; Laura Muirhead; Zsolt Bodai; Francesca Rosini; Abigail V M Speller; Sami Shousha; Rathi Ramakrishnan; Ara Darzi; Zoltan Takats; Daniel R Leff
Journal:  Breast Cancer Res       Date:  2017-05-23       Impact factor: 6.466

9.  Fewer Reoperations After Lumpectomy for Breast Cancer with Neoadjuvant Rather than Adjuvant Chemotherapy: A Report from the National Cancer Database.

Authors:  Jeffrey Landercasper; Barbara Bennie; Benjamin M Parsons; Leah L Dietrich; Caprice C Greenberg; Lee G Wilke; Jared H Linebarger
Journal:  Ann Surg Oncol       Date:  2017-01-06       Impact factor: 5.344

10.  Reoperation after breast-conserving surgery for cancer in Australia: statewide cohort study of linked hospital data.

Authors:  Marina T van Leeuwen; Michael O Falster; Claire M Vajdic; Philip J Crowe; Sanja Lujic; Elizabeth Klaes; Louisa Jorm; Art Sedrakyan
Journal:  BMJ Open       Date:  2018-04-10       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.